View in EDS HTML Full Text PDF Full Text

Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib.

Saved in:
Bibliographic Details
Title: Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib.
Authors: Kawczak, Piotr1 (AUTHOR) piotr.kawczak@gumed.edu.pl, Bączek, Tomasz1,2 (AUTHOR)
Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 6, p2387. 34p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm15062387